Transaction #14146 · Form 4 · 0001796536-25-000005
BeOne Medicines Ltd. · Exercise / conversion · American Depositary Shares
BeOne Medicines Ltd. · Transacted November 26, 2025 · Filed December 1, 2025
What does this filing report?
An SEC Form 4 filing for BeOne Medicines Ltd. records an exercise / conversion involving American Depositary Shares on November 26, 2025. The reported quantity was 2,627. The filing date is December 1, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- BeOne Medicines Ltd.
- Company CIK
- 0001651308
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 2,627
- Reported price
- 159.03
- Reference value
- 417,771.81
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 2,627
- Ownership description
- Not reported
- SEC acceptance time
- Dec 1, 2025, 4:57 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Sanders Corazon (Corsee) D. ↗
Director
CIK 0001796536
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Filing footnotes & remarks
- F1
- Each American Depositary Share represents 13 Ordinary Shares.
- F2
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $340.04 to $340.68, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F3
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $342.42 to $342.675, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F4
- The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.
- F5
- The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors (the "Board") or otherwise ceases to serve as a director, unless the Board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.